SCHEMBL26050172

SCHEMBL26050172

BC(B)(c1cnc(-c2ccccc2)cc1C)C(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LDHA P00338 1/20 0.48
▸ RAB9A P51151 3/20 0.40
▸ NPC1 O15118 3/20 0.40
▸ PDGFRB P09619 1/20 0.40
▸ KDR P35968 1/20 0.40
▸ FLT3 P36888 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ PKM P14618 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ IDO1 P14902 3/20 0.35
▸ TDO2 P48775 3/20 0.35
▸ CYP11B1 P15538 2/20 0.34
▸ CYP11B2 P19099 2/20 0.34
▸ GSK3A P49840 1/20 0.34
▸ GSK3B P49841 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23912221 0.88 LDHA (0.40) LDHARAB9ANPC1PDGFRBKDR
SCHEMBL22037131 0.84 CYP1A2 (0.40) RAB9ANPC1SMN1; SMN2KDM4EALDH1A1
SCHEMBL24700060 0.82 LDHA (0.36) LDHARAB9ANPC1PDGFRBKDR
SCHEMBL23817590 0.82 LDHA (0.36) LDHARAB9ANPC1PDGFRBKDR
SCHEMBL26009607 0.81 LDHA (0.35) LDHARAB9ANPC1PDGFRBKDR
SCHEMBL26260936 0.81 LDHA (0.38) LDHARAB9ANPC1PDGFRBKDR
SCHEMBL25137952 0.80 ACHE (0.36) LDHARAB9ANPC1KMT2AIDO1
SCHEMBL25836140 0.80 LDHA (0.35) LDHARAB9ANPC1PDGFRBKDR
SCHEMBL24701251 0.79 LDHA (0.54) LDHARAB9ANPC1PDGFRBKDR
SCHEMBL26290575 0.74 LDHA (0.49) LDHARAB9ANPC1PDGFRBKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11739081-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-08-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11739081-B2 Organic electroluminescent materials and devices ICMT, KCNQ2, KCNQ1 LDHA 58/4885RAB9A 474/4885NPC1 3490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback